Liver transplantation for hepatocellular carcinoma in clinical practice: The lesson from a 20-year multicentre experience in Italy

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 2, 2012, Pages 195-202

  Farinati, Fabio ^a   Giacomin, Anna ^a   Vanin, Veronica ^a   Sergio, Adriana ^a   Burra, Patrizia ^a   Cillo, Umberto ^a   Di Nolfo, Annamaria ^c   Del Poggio, Paolo ^d   Benvegnu, Luisa ^a   Zoli, Marco ^e   Borzio, Franco ^f   Giannini, Edoardo G ^g   Caturelli, Eugenio ^h   Cazzagon, Nora ^b   Rapaccini, Gian Ludovico ⁱ   Trevisani, Franco ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c BOLOGNINI HOSPITAL   (Italy)

^d Treviglio Caravaggio Hospital   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g UNIVERSITY OF GENOA   (Italy)

^h Hospital Belcolle   (Italy)

ⁱ CATHOLIC UNIVERSITY   (Italy)

Author keywords

evidence based approach; guidelines; hepatocellular carcinoma; liver transplantation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CLINICAL PRACTICE; DATA BASE; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; ITALY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL;

AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGIC METHODS; FEMALE; GUIDELINE ADHERENCE; HUMANS; ITALY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; TREATMENT OUTCOME;

EID: 84855896328     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32834e153c     Document Type: Article

References (32)

1. Starzl TE, Marchioro TL, Vonkaulla KN, Hemann G, Brittain RS,Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963; 117:659-676.
2. Ishizaki Y, Kawasaki S. The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J. Gastroenterol. 2008; 43:18-26. (Pubitemid 351324981)
3. Freeman RB Jr. Transplantation for hepatocellular carcinoma: The Milan criteria and beyond. Liver Transpl 2006; 12 (11 Suppl 2):S8-S13. (Pubitemid 44742516)
4. Sharma P, Harper AM, Hernandez JL, Heffron T, Mulligan DC,Wiesner RH, et al. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation. Am J Transpl 2006; 6:1957-1962. (Pubitemid 44024970)
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699. (Pubitemid 26079803)
6. United Network for Organ Sharing, Policy 3.6. Available at: http:// optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp [Accessed 26 October 2011].
7. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy. Gastroenterology 2004; 127 (Suppl):S261-S267. (Pubitemid 39423395)
8. Yao FY, Ferrel L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403. (Pubitemid 32496976)
9. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: Validation of the UCSFexpanded criteria based on preoperative imaging. Am J Transplant 2007; 7:2587-2594.
10. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ 3rd, Bass NM, Feng S, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis. Hepatology 2008; 48:819-827.
11. Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008; 248:617-625.
12. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Ercolani G, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8:2547-2557.
13. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, Zanus G, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004; 239:150-159. (Pubitemid 38176347)
14. Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: Prognostic parameters. Transplant Proc 2005; 37:1693-1694. (Pubitemid 40790798)
15. Cillo U, Vitale A, Navaglia F, Basso D, Montin U, Bassanello M, et al. Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma. World J. Gastroenterol. 2005; 11:6920-6925. (Pubitemid 43126047)
16. Majno P, Mazzaferro V. Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria: questions, answers and demands for a common language. Liver Transpl 2006; 12:896-898. (Pubitemid 43960362)
17. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 2008; 15:1001-1007.
18. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al.; on behalf of the Metroticket Investigator Study Group. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009; 10:35-43.
19. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35:421-430.
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236. (Pubitemid 43112690)
21. Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology 2011; 53:1020-1022.
22. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002; 20:1527-1536. (Pubitemid 34260532)
23. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma; a retrospective study of 435 patients. Hepatology 1998; 28:751-755.
24. Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC Di Nolfo MA, et al. Italian Liver Cancer (ITA.LI.CA) Group. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. Am J. Gastroenterol. 2007; 102:1022-1031. (Pubitemid 46698223)
25. Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, et al. Italian Liver Cancer (ITALICA) group. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: Effects on cancer staging and patient survival. Am J. Gastroenterol. 2004; 99:1470-1476. (Pubitemid 39180093)
26. Trevisani F, De Notariis S, Rapaccini G, Farinati F, Benvegnù L, Zoli M, et al.; Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: Effects on cancer stage and patient survival (Italian experience). Am J. Gastroenterol. 2002; 97:734-744. (Pubitemid 34245906)
27. Pugh RN, Murray-Lyon I, Dawson J, Pietroni MC, Williams R. Transsection of the oesopahagus for bleeding oesophageal varices. Br J Surg 1973; 60:646-649.
28. Braillon A. Hepatocellular carcinoma and evidence-based surgery. World J. Gastroenterol. 2009; 15:5371.
29. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the scientific registry of transplant recipients database. Hepatology 2009; 49:832-838.
30. Yao FY. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008; 8:1982-1989.
31. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54:1151-1156.
32. Schwartz ME, D'Amico F, Vitale A, Emre S, Cillo U. Liver transplantation for hepatocellular carcinoma: Are the Milan criteria still valid? Eur J Surg Oncol 2008; 34:256-262. (Pubitemid 351312865)